API manufacturing

Inspection concluded at its API manufacturing facility in Srikakulam, Andhra Pradesh

Equipped with Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs 200…

The inspection closed with zero observations

Dr Sanjay Chaturvedi, ED and CEO, IOL Chemicals and Pharmaceuticals stresses that as the Indian pharmaceutical industry continues…

While formulation generics flounders a bit, the data show that the Indian API industry has done better, with a five-year revenue…

CMOs can benefit from investing in capabilities and expertise to produce and handle sensitive biologics, as the marketed drugs…

The company did not reveal the name of the global pharmaceutical firm and the value of the deal

Dr RB Smarta, CMD, Interlink and VP, HADSA elaborates on ten trends that will greatly influence the pharma industry in 2021-22

Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, and Ishani Jain, Member, Pharma and Life Sciences Practice…

The Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug…